» Articles » PMID: 21051746

Recurrent Deep Intronic Mutations in the SLC12A3 Gene Responsible for Gitelman's Syndrome

Overview
Specialty Nephrology
Date 2010 Nov 6
PMID 21051746
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Objectives: Gitelman's syndrome (GS) is an autosomal recessive renal tubular disorder caused by mutations in the SLC12A3 gene encoding the thiazide-sensitive Na(+)-Cl(-) cotransporter (NCC). Despite meticulous sequencing of genomic DNA, approximately one-third of GS patients are negative or heterozygotes for the known mutations.

Design, Setting, Participants, & Measurements: Because blood leukocytes express NCC mRNA, we evaluate whether deep intronic mutations contribute to GS patients with uniallelic or undetectable SLC12A3 mutations. Twenty-nine patients with GS (men/women = 16/13), including eight negative and 21 uniallelic SLC12A3 mutations from 19 unrelated families, and normal controls were enrolled in an academic medical center. Analysis of cDNA from blood leukocytes, sequencing of the corresponding introns of genomic DNA for abnormal transcript, and analysis of NCC protein expression from renal biopsy were performed.

Results: We identified nine Taiwan aboriginal patients carrying c.1670-191C→T mutations in intron 13 and 10 nonaboriginal patients carrying c.2548+253C→T mutations in intron 21 from 14 families (14/19). These two mutations undetected in 100 healthy subjects created pseudoexons containing new premature termination codons. Haplotype analysis with markers flanking SLC12A3 revealed that both mutations did not have founder effects. Apical NCC expression in the DCT of renal tissue was markedly diminished in two patients carrying deep intronic mutations.

Conclusions: Deep intronic mutations in SLC12A3 causing defective NCC expression can be identified with the RNA-based approach in patients with GS. c.1670-191C→T and c.2548+253C→T are hot spot mutations that can be screened in GS patients with uniallelic or negative SLC12A3 mutations.

Citing Articles

A novel homozygous SLC12A3 mutation causing Gitelman syndrome with co-existent autoimmune thyroiditis: a case report and review of the literature.

Koca O, Alay M, Murt A, Kalayci Yigin A, Seven M, Bavunoglu I CEN Case Rep. 2024; 13(5):330-338.

PMID: 38308744 PMC: 11442957. DOI: 10.1007/s13730-023-00845-z.


Novel Intronic Mutations of the Gene in Patients with Gitelman Syndrome.

Xun Z, Gao P, Du Y, Yan X, Yang J, Wang Z Int J Gen Med. 2023; 16:1797-1806.

PMID: 37197138 PMC: 10184854. DOI: 10.2147/IJGM.S408631.


The Contribution of Splicing Variants to the Pathogenesis of X-Linked Alport Syndrome.

Yamamura T, Horinouchi T, Aoto Y, Lennon R, Nozu K Front Med (Lausanne). 2022; 9:841391.

PMID: 35211492 PMC: 8861460. DOI: 10.3389/fmed.2022.841391.


Analysis of Pathogenic Pseudoexons Reveals Novel Mechanisms Driving Cryptic Splicing.

Keegan N, Wilton S, Fletcher S Front Genet. 2022; 12:806946.

PMID: 35140743 PMC: 8819188. DOI: 10.3389/fgene.2021.806946.


Molecular Basis, Diagnostic Challenges and Therapeutic Approaches of Bartter and Gitelman Syndromes: A Primer for Clinicians.

Nunez-Gonzalez L, Carrera N, Garcia-Gonzalez M Int J Mol Sci. 2021; 22(21).

PMID: 34768847 PMC: 8584233. DOI: 10.3390/ijms222111414.


References
1.
Reissinger A, Ludwig M, Utsch B, Promse A, Baulmann J, Weisser B . Novel NCCT gene mutations as a cause of Gitelman's syndrome and a systematic review of mutant and polymorphic NCCT alleles. Kidney Blood Press Res. 2003; 25(6):354-62. DOI: 10.1159/000068695. View

2.
Lin S, Shiang J, Huang C, Yang S, Hsu Y, Cheng C . Phenotype and genotype analysis in Chinese patients with Gitelman's syndrome. J Clin Endocrinol Metab. 2005; 90(5):2500-7. DOI: 10.1210/jc.2004-1905. View

3.
Lemmink H, Knoers N, Karolyi L, Van Dijk H, Niaudet P, Antignac C . Novel mutations in the thiazide-sensitive NaCl cotransporter gene in patients with Gitelman syndrome with predominant localization to the C-terminal domain. Kidney Int. 1998; 54(3):720-30. DOI: 10.1046/j.1523-1755.1998.00070.x. View

4.
Peters M, Jeck N, Reinalter S, Leonhardt A, Tonshoff B, Klaus G G . Clinical presentation of genetically defined patients with hypokalemic salt-losing tubulopathies. Am J Med. 2002; 112(3):183-90. DOI: 10.1016/s0002-9343(01)01086-5. View

5.
Zelikovic I, Szargel R, Hawash A, Labay V, Hatib I, Cohen N . A novel mutation in the chloride channel gene, CLCNKB, as a cause of Gitelman and Bartter syndromes. Kidney Int. 2002; 63(1):24-32. DOI: 10.1046/j.1523-1755.2003.00730.x. View